Evidence map›Paper›PMID 30837188›Full record

ArticleBrazilian journal of otorhinolaryngology

Prevention of upper aerodigestive tract cancer through active search strategies and use of equipped propaedeutics.

Francis Balduino Guimarães Santos, Fernando Danelon Leonhardt, Márcio Abrahão

Abstract read
In one paragraph

Article in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Francis Balduino Guimarães SantosUniversidade Estadual de Montes Claros (Unimontes), Curso de Medicina, Montes Claros, MG, Brazil. Electronic address: franbal@terra.com.br.
Fernando Danelon LeonhardtUniversidade Federal de São Paulo (Unifesp), Programa de Pós-Graduação em Otorrinolaringologia (PPG/ORL), São Paulo, SP, Brazil.
Márcio AbrahãoUniversidade Federal de São Paulo (Unifesp), Programa de Pós-Graduação em Otorrinolaringologia (PPG/ORL), São Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionUpper aerodigestive tract cancer is among the most frequent malignancies and has epidemiological importance worldwide. Most cases are already advanced at the diagnosis, with a strong negative impact on survival and high cost to the government. Campaigns directed against these cancers have often failed in Brazil.

objectiveTo evaluate the effectiveness of screening for upper aerodigestive tract cancers, using active search strategies and the use of equipped propaedeutics.

methodsA cross-sectional, prospective, descriptive, analytical and exploratory study, since its objectives are based on the visualization of cancerous lesions in a sample consisting of individuals with risk factors, aiming to expand the necessary knowledge for cancer detection, aiming at secondary prevention of the oral cavity, oropharynx, larynx and hypopharynx cancer.

resultsA total of 16.7% of precancerous lesions and 0.5% of cancer lesions located in the upper aerodigestive tract were clinically visualized.

conclusionThe method was effective in the identification of precancerous lesions for the purpose of secondary prevention, but equally important against upper aerodigestive tract cancer, since in the present study the chance of finding the latter was increased by 22.7, showing it is an alternative for future campaigns against the disease.

Indexed as

Mouth NeoplasmsBrazilCross-Sectional StudiesHumansProspective StudiesNeoplasia do trato aerodigestivo superiorPrevalencePrevalênciaPrevenção secundáriaSecondary preventionUpper aerodigestive tract neoplasia

Identifiers

PMID30837188
PMCPMC9422600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.